Back to Semaglutide research
semaglutide glp 1 agonist other 2024-06-11 ClinicalTrials

Long-Term Wegovy Safety and Effectiveness Monitored in Real-World Obesity Study in Japan

Special Use - Results Surveillance on Long-term Use With Wegovy®

Abstract

A Multi-centre, Prospective, Non-interventional, Single-armed, 104 Weeks Post-marketing Study to Investigate Safety and Clinical Parameters of Wegovy® Once Weekly in Patients With Obesity Disease Under Real-world Clinical Practice Condition…

semaglutide glp 1 agonist glp-1r protocol relevant
Source: clinicaltrials:NCT06283667 · Ingested 2026-04-06 · Digest: gemini-2.5-flash